Charcot-Marie-Tooth Disease Caused by Mutation in the MPZ Gene

Charcot-Marie-Tooth disease caused by mutation in the MPZ gene is a rare, inherited nerve disease that mainly affects the nerves in the legs, feet, hands, and arms. The MPZ gene gives the “recipe” for a protein called myelin protein zero (P0), which is very important for the myelin sheath – the fatty, protective cover that wraps around peripheral nerves like insulation around an electric wire. When MPZ is changed (mutated), the myelin becomes weak or abnormal, so nerve signals travel more slowly or are partly lost. Over many years this leads to slowly progressive weakness, muscle wasting, numbness, foot deformities (such as high-arched feet), and walking problems. MPZ mutations most often cause Charcot-Marie-Tooth type 1B (CMT1B), but they can also cause axonal forms (CMT2) and intermediate forms of CMT, and the severity can range from very mild adult-onset disease to severe weakness starting in infancy. Orpha.net+2Muscular Dystrophy Association+2

Charcot-Marie-Tooth disease (CMT) caused by a mutation in the MPZ gene is a hereditary nerve disease that mainly affects the legs, feet, hands, and arms. The MPZ gene makes a protein called myelin protein zero (P0). This protein is a major building block of the myelin sheath, which is the “insulation” around peripheral nerves. When the MPZ gene is changed (mutated), the myelin does not form or stay healthy. This leads to slow and weak nerve signals, causing muscle weakness, foot deformities, balance problems, and loss of feeling, usually starting in childhood or early adult life.Genetic Rare Diseases Center+1

How MPZ mutation causes Charcot-Marie-Tooth disease

In healthy nerves, Schwann cells wrap myelin around the nerve like layers of tape around a wire. Myelin protein zero (from the MPZ gene) helps these layers stick tightly together so messages can travel quickly and smoothly. When the MPZ gene has a mutation, the protein may be wrongly shaped or missing parts. This damaged protein cannot hold the myelin layers together properly, so the myelin becomes thin, loose, or breaks down. Over time the nerve fibres conduct signals more slowly or not at all. This causes weakness in the small muscles of the feet and hands, difficulty walking, tripping, foot drop, and later weakness in hands, along with numbness or burning pain.Wikipedia+2NCBI+2

---

Other names

Charcot-Marie-Tooth disease due to MPZ mutation is known by several other medical names. These names are used in research papers, genetic reports, and hospital notes, but they all describe very similar or overlapping conditions.

One common name is Charcot-Marie-Tooth disease type 1B (CMT1B). This is the classical demyelinating form where nerve conduction is slow because the myelin is damaged. It is usually inherited in an autosomal dominant way, which means one changed MPZ gene from either mother or father is enough to cause disease. Orpha.net+1

Another group of names is hereditary motor and sensory neuropathy type I (HMSN I) or HMSN Ib. “Hereditary” means genetic, “motor and sensory” means it affects both movement and feeling, and “neuropathy” means a disease of the nerves. These terms are older but still used in many neurology books and genetic databases. MalaCards

Some patients with MPZ mutation are described as having dominant intermediate Charcot-Marie-Tooth disease type D (CMTDID). “Intermediate” means that the nerve conduction tests show values between typical demyelinating CMT and typical axonal CMT. This happens because MPZ mutations can sometimes damage both myelin and the underlying axon. Frontiers+1

In severe early-onset cases, the same gene can be linked with Dejerine–Sottas disease (CMT3) or congenital hypomyelinating neuropathy. These names are used when weakness, poor muscle tone, and delayed milestones appear in infancy, and nerve biopsies show very little or very thin myelin. MalaCards+1

Some databases also list names like peroneal muscular atrophy, Charcot-Marie-Tooth neuropathy type 1B, and similar phrases, all pointing to the same basic idea: a slowly progressive, inherited neuropathy mainly caused by pathogenic variants in MPZ. MalaCards+1

---

Types of MPZ-related Charcot-Marie-Tooth disease

Because MPZ mutations can affect nerves in different ways, doctors describe several types of MPZ-related CMT. These types are based on nerve conduction studies, age at onset, and clinical severity.

1. CMT1B (demyelinating type)
CMT1B is the most typical MPZ-related form. In this type, motor nerve conduction is significantly slowed, usually below 38 m/s in the arms. This slowing shows that the myelin sheath is damaged or poorly formed. Patients often have childhood onset with distal weakness, high-arched feet, and loss of ankle reflexes. Orpha.net+1

2. Axonal forms (CMT2I, CMT2J)
Some MPZ mutations mostly damage the axon (the long fiber of the nerve) rather than the myelin, and these are called CMT2I or CMT2J. In these forms, nerve conduction speed may be near normal, but the size of the electrical response is reduced because there are fewer functioning axons. Patients may present later in life with foot drop and sensory loss. Nature

3. Dominant intermediate CMT (CMTDID)
In dominant intermediate CMT due to MPZ, the nerve conduction speed is in an intermediate range, not clearly demyelinating and not clearly axonal. Clinically, patients have mixed features, and the disease may be moderate in severity. This pattern reflects combined damage to myelin and axons from specific MPZ changes. Frontiers+1

4. Dejerine–Sottas disease (CMT3) due to MPZ
Certain severe MPZ mutations cause very early-onset neuropathy with delayed motor milestones, hypotonia, and often wheelchair use in childhood. Nerve conduction is extremely slow, and nerve biopsies show thickened myelin with “onion bulb” formations from repeated demyelination and remyelination. MalaCards+1

5. Congenital hypomyelinating neuropathy due to MPZ
In this rare form, babies are born with very weak muscles, poor sucking, and delayed development. Nerve studies show almost no myelin, and MPZ mutations are one of the known genetic causes. This form is at the severe end of the MPZ disease spectrum. Nature+1

6. Pain-predominant small-fiber neuropathy phenotype
Recent case series show that some MPZ mutations give a pain-predominant phenotype, where patients mainly suffer from burning pain and small-fiber involvement rather than obvious weakness at the beginning. This reminds clinicians that MPZ-related CMT can sometimes present mainly as small-fiber neuropathy. PMC+1

---

Causes

In MPZ-related CMT, the main cause is always a genetic change (mutation) in the MPZ gene. But there are many different ways this can happen and many mechanisms by which the mutated gene harms the nerve. Below are 20 simple “cause or mechanism” points that explain this.

1. Inherited autosomal dominant MPZ mutation
Most people with MPZ-related CMT inherit one mutated copy of MPZ from an affected parent. Because the condition is autosomal dominant, having just one changed copy is enough to disturb myelin and cause neuropathy in each generation. Orpha.net+1

2. De novo MPZ mutation
Sometimes, a child has a new MPZ mutation that was not present in either parent. This is called a de novo mutation and can cause CMT in a family with no previous history, which is often discovered by genetic testing. Nature+1

3. Missense mutations in the extracellular domain
A common type of MPZ mutation changes a single amino acid in the extracellular domain of the protein. This region helps one myelin layer stick to another. When it is altered, myelin layers do not compact properly, leading to unstable myelin and slow nerve conduction. PMC+1

4. Mutations in the transmembrane region
Some mutations affect the part of MPZ that sits in the Schwann cell membrane. These changes can disturb how the protein is anchored in the membrane and how it interacts with other myelin proteins, causing myelin breakdown and nerve dysfunction. Wiley Online Library+1

5. Truncating (nonsense) mutations
Nonsense mutations create a premature stop signal in the gene, so the protein is too short. This truncated MPZ cannot function properly and may be quickly destroyed in the cell, leading to reduced myelin stability and neuropathy. Wiley Online Library+1

6. Frameshift mutations
Frameshift mutations add or remove small pieces of DNA so that the reading frame of the gene changes. This usually produces a completely altered C-terminal tail of MPZ, which can have toxic effects on Schwann cells and cause severe demyelinating CMT. Nature

7. Splice-site mutations
Splice-site mutations occur at the boundaries between exons and introns and disrupt normal RNA splicing. This can lead to missing exons or inclusion of intronic sequences, creating abnormal MPZ protein that cannot maintain normal myelin. Wiley Online Library+1

8. Gain-of-function toxic MPZ protein
Some MPZ mutations do not simply reduce protein function but create a protein that is actively toxic to the Schwann cell. The mutated MPZ protein may misfold, form aggregates, or disturb cell signaling, which damages myelin sheaths even when the amount of protein is normal. Nature

9. Loss-of-function MPZ deficiency
Other mutations mainly reduce the amount or activity of MPZ, so the myelin layers cannot compact tightly. The resulting loose myelin is fragile, and conduction becomes slow, leading to classic features of CMT1B. PMC+1

10. Misfolded MPZ and endoplasmic reticulum stress
Misfolded MPZ can accumulate inside the Schwann cell’s endoplasmic reticulum (ER). This triggers the unfolded protein response and chronic ER stress, which in turn leads to Schwann cell dysfunction and demyelination. Nature

11. Disturbed myelin compaction and onion bulb formation
MPZ is a major structural protein of peripheral myelin. When it is abnormal, myelin layers cannot compact properly, and repeated attempts to repair myelin form “onion bulb” structures around axons, a hallmark of CMT1B seen on nerve biopsy. PMC+1

12. Abnormal balance of large MPZ isoform (L-MPZ)
Experimental studies in animals show that up-regulation of the large isoform of MPZ (L-MPZ) can create CMT-like neuropathy. An abnormal ratio of MPZ isoforms may also contribute to human disease when mutations alter how the gene is used. Nature

13. Disrupted interaction with other myelin proteins
Myelin is made from several proteins, including PMP22, connexins, and periaxin. MPZ mutations can disturb how these proteins work together in the myelin sheath, increasing the risk of demyelination and axonal damage. Wikipedia+1

14. Mixed demyelinating and axonal injury (intermediate CMT)
Some MPZ mutations cause both demyelination and direct axonal damage. This mixed mechanism explains the intermediate nerve conduction speeds in CMTDID and the clinical picture that lies between classical demyelinating and axonal forms of CMT. Frontiers+1

15. Early developmental effects on Schwann cells
Certain severe MPZ mutations disturb Schwann cell development very early in life. As a result, myelin never forms properly, causing congenital hypomyelinating neuropathy or Dejerine–Sottas disease with severe, early-onset weakness. MalaCards+1

16. Phenotype modification by other genes
Different people with the same MPZ mutation can have very different severity. Research suggests that other genetic variants (modifier genes) can increase or decrease the damage caused by MPZ mutations, changing the age at onset and progression. Nature+1

17. Somatic or germline mosaicism
In some families, a parent may carry the MPZ mutation only in some cells (mosaicism) and may have very mild or no symptoms. However, the child can inherit the mutation in all cells and develop clear CMT, making mosaicism another mechanism behind “new” cases. Orpha.net+1

18. MPZ mutations linked with small-fiber involvement
Specific MPZ variants can preferentially affect small nerve fibers that carry pain and temperature. This can lead to painful small-fiber neuropathy as a main feature and is a mechanistic cause of unusual painful presentations in MPZ-related CMT. PMC+1

19. Age-related axonal degeneration on top of genetic damage
Even when the primary damage is demyelination, long-term stress on the axon can cause secondary axonal loss as patients age. This age-related axonal degeneration adds to disability over time in people with MPZ mutations. PNAS+1

20. Environmental and metabolic modifiers (not primary cause)
Factors such as diabetes, alcoholism, poor nutrition, or neurotoxic drugs (for example some chemotherapy agents) do not cause MPZ-related CMT by themselves, but they can worsen nerve damage and symptoms in patients who already carry an MPZ mutation. Doctors therefore advise strict control of such risk factors. MedlinePlus+1

---

Symptoms

Symptoms of MPZ-related CMT usually start slowly and get worse over many years. They mainly affect the feet and legs first, and later the hands and arms.

1. Weakness of feet and ankles
One of the earliest symptoms is weakness in the muscles that lift the foot. Patients may notice that they cannot run as fast as before or that their feet feel heavy or clumsy when walking. Orpha.net+1

2. Foot drop and frequent tripping
Because the ankle muscles are weak, the front of the foot may drag on the ground, a problem called foot drop. This leads to stumbles and falls, especially on uneven ground or when walking quickly. MedlinePlus+1

3. High-arched feet (pes cavus)
Over time, the imbalance between different foot muscles causes the arch to become very high and rigid. This deformity, called pes cavus, is a classic sign of CMT and often brings patients to the attention of orthopedics or neurology. Orpha.net+1

4. Hammertoes
Toe muscles also become imbalanced, and the toes bend in a claw-like or hammer-like position. These hammertoes can rub in shoes and cause pain, calluses, and difficulty finding comfortable footwear. MedlinePlus+1

5. Wasting of lower leg muscles (“stork legs”)
When the calf muscles shrink from long-standing denervation, the lower legs look thin, with loss of bulk around the shins and calves, while the thighs may appear relatively preserved. This gives the typical “stork leg” appearance seen in many CMT patients. MedlinePlus+1

6. Hand weakness and clumsiness
Later in the disease, weakness and wasting spread to the small muscles of the hands. Patients may notice difficulty fastening buttons, opening jars, or doing fine tasks at work, especially in jobs that need precise hand control. Orpha.net+1

7. Numbness in feet and hands
Sensory symptoms are very common. Patients often describe numbness or “dead” feeling in the feet and sometimes in the hands. They may not feel small injuries or temperature changes, which can increase the risk of unnoticed cuts or burns. MedlinePlus+1

8. Tingling, burning, or electric-like pain
Some MPZ mutations, especially those linked to small-fiber involvement, cause burning, tingling, or electric shocks in the feet and legs. This neuropathic pain can be constant or come in bursts and may interfere with sleep and daily life. PMC+1

9. Reduced vibration and position sense
Patients may lose the ability to feel vibration from a tuning fork or to sense the exact position of their toes and fingers. This loss of “deep” sensation makes balance worse and contributes to unsteady walking, especially in the dark. MedlinePlus+1

10. Reduced or absent tendon reflexes
Reflexes at the ankles and knees often become weak or absent, which is a common finding on neurological examination. Patients usually do not notice this themselves, but it helps doctors recognize peripheral neuropathy. Orpha.net+1

11. Fatigue with walking or standing
Even in mild disease, patients often feel tired more quickly when walking or standing for long periods because their weakened muscles have to work harder. This can limit participation in work or social activities. MedlinePlus+1

12. Balance problems and unsteady gait
Because of muscle weakness and loss of sensation, patients may have difficulty keeping balance, especially when turning quickly, walking on uneven surfaces, or standing with feet together and eyes closed. Falls are a risk, particularly in older patients. MedlinePlus+1

13. Hand cramps and muscle stiffness
Some people experience muscle cramps or stiffness in hands and feet, especially after repeated use. These cramps are uncomfortable but usually not dangerous, although they add to functional difficulty. MedlinePlus+1

14. Skeletal deformities and scoliosis
In some patients, long-term muscle imbalance leads to deformities not only in the feet but also in the spine, such as mild scoliosis. These skeletal issues can worsen posture and back pain over time. Wikipedia+1

15. Emotional and social impact
Living with chronic weakness, pain, and visible deformities can cause anxiety, low mood, and social withdrawal. Many patients worry about work, walking safety, and passing the condition to children. Recognizing and treating this emotional impact is an important part of holistic care. MedlinePlus+1

---

Diagnostic tests

Diagnosing Charcot-Marie-Tooth disease due to MPZ mutation involves several steps. Doctors start with history and examination and then use laboratory tests, nerve studies, imaging, and genetic tests to confirm the type and the gene involved.

Physical examination tests

1. Full neurological examination
The neurologist checks muscle strength, tone, sensation, and coordination in all limbs. In MPZ-related CMT, this exam often shows distal muscle weakness, wasting in the feet and calves, reduced reflexes, and sensory loss in a “glove and stocking” pattern, guiding the doctor to suspect a hereditary neuropathy. Orpha.net+1

2. Gait and posture assessment
The doctor watches how the patient walks, turns, and stands. A high-stepping gait, foot drop, poor heel or toe walking, and use of widened stance for balance are typical. These findings help distinguish neuropathic gait from muscle or joint problems. MedlinePlus+1

3. Inspection of feet and legs
Careful visual inspection often shows high-arched feet, hammertoes, calluses, and calf muscle wasting. Comparing both sides helps confirm that the changes are symmetrical, supporting a diagnosis of hereditary neuropathy rather than a single-nerve injury. Orpha.net+1

4. Reflex testing
Using a reflex hammer, the doctor checks ankle, knee, and other tendon reflexes. In CMT1B and other MPZ-related forms, ankle reflexes are usually absent and knee reflexes may be reduced, which is a classic sign of chronic peripheral neuropathy. Orpha.net+1

5. Functional hand and daily activity tests
The clinician may ask the patient to button a shirt, write, or pick up small objects. Difficulty with these tasks suggests hand muscle weakness and coordination problems, helping to stage the severity and impact on daily life. MedlinePlus+1

Manual bedside tests

6. Manual muscle testing (MRC grading)
The doctor uses hands to resist the patient’s muscle movements and grades strength from 0 to 5 using the Medical Research Council (MRC) scale. In MPZ-related CMT, distal muscles in the feet and hands usually show the most weakness, which can be followed over time to monitor progression. MedlinePlus+1

7. Tinel’s sign and peripheral nerve palpation
The clinician may gently tap over nerves at the ankle or wrist to see if this causes tingling. In MPZ-CMT, this helps distinguish superimposed entrapment neuropathies, which can occur in some patients with MPZ mutations and may need separate treatment. ScienceDirect+1

8. Romberg test
The patient stands with feet together and eyes closed while the doctor observes for swaying or loss of balance. A positive Romberg sign suggests sensory ataxia from reduced position sense in the feet, which is common in sensory neuropathies like CMT. MedlinePlus+1

9. Heel-toe and tandem walking tests
The patient is asked to walk on heels, on toes, and in a straight line placing one foot directly in front of the other. Weakness of ankle dorsiflexors and poor balance make these tasks difficult in MPZ-related CMT and help document functional impairment. MedlinePlus+1

10. Vibration and joint position sense testing
Using a tuning fork on the ankles and toes and gentle movement of joints, the doctor checks vibration and position sense. Loss of these senses is typical in CMT and correlates with risk of falls and instability, especially in dark conditions. MedlinePlus+1

Lab and pathological tests

11. Routine blood tests to rule out acquired causes
Blood tests such as glucose, vitamin B12, thyroid function, kidney and liver tests are performed to exclude acquired neuropathies like diabetic or nutritional neuropathy. Normal results with a strong family history make hereditary CMT, including MPZ-related forms, more likely. MedlinePlus+1

12. Targeted CMT gene panel including MPZ
Modern genetic panels test many CMT-related genes at once, including MPZ. If a known pathogenic MPZ variant is found and matches the clinical picture, this confirms the diagnosis at the molecular level and helps with family counseling. Orpha.net+1

13. Whole-exome or whole-genome sequencing
When panel testing is negative or when the phenotype is unusual, broad sequencing (exome or genome) can detect rare or novel MPZ variants. These methods have identified many new MPZ mutations and expanded the known spectrum of MPZ-related CMT. Frontiers+1

14. Segregation analysis in family members
Once an MPZ variant is found, testing other family members helps show whether the variant tracks with disease. If the variant is present in all affected relatives and absent in unaffected ones, this supports its role as the cause of CMT in that family. Nature+1

15. Nerve biopsy and histopathology (selected cases)
In difficult or older cases, a sural nerve biopsy may be done. In CMT1B, the biopsy can show demyelination, remyelination, and onion bulb formations, and immunostaining can demonstrate altered MPZ. Today, biopsy is used less often because genetic testing is widely available, but it still has a role in selected situations. PMC+1

Electrodiagnostic tests

16. Motor nerve conduction studies
Electrodiagnostic tests measure how fast and how strongly nerves carry electrical signals. In demyelinating MPZ-related CMT (CMT1B), motor conduction velocities are significantly slow, while amplitudes may be relatively preserved early on. This pattern strongly suggests a hereditary demyelinating neuropathy. PNAS+1

17. Sensory nerve conduction studies
Sensory responses from nerves such as the sural or median nerve are recorded. In many MPZ-related cases, sensory potentials are reduced or absent, especially in the legs, confirming a length-dependent sensory neuropathy. ScienceDirect+1

18. Needle electromyography (EMG)
Fine needles are inserted into muscles to record electrical activity at rest and during contraction. In chronic MPZ-related neuropathy, EMG may show signs of long-standing denervation and reinnervation, such as large motor unit potentials, helping to assess severity and chronicity. ScienceDirect+1

Imaging tests

19. Nerve ultrasound (peripheral nerve sonography)
High-resolution ultrasound can show the size and pattern of peripheral nerves. In MPZ-related CMT, ultrasound may reveal moderately enlarged nerves with specific distribution patterns, offering a non-invasive way to support diagnosis and to differentiate MPZ-related neuropathy from other CMT subtypes. ScienceDirect

20. MRI neurography or spinal imaging
Magnetic resonance imaging (MRI) of peripheral nerves or nerve roots can demonstrate nerve enlargement and signal changes in hereditary neuropathies, and also helps exclude other causes such as nerve root compression. In research settings, MRI contributes to understanding how MPZ mutations affect nerve structure over time. ScienceDirect+1

Non-pharmacological treatments (therapies and other approaches)

There is no cure and no disease-modifying drug for CMT at this time. Management is mainly supportive and rehabilitative. A team may include neurologists, physiatrists, physiotherapists, occupational therapists, orthotists, podiatrists, and surgeons.Taylor & Francis Online+4NCBI+4Physiopedia+4
Below are key non-drug treatments. They do not fix the gene, but they help you move better, reduce pain, and slow complications.

1. Individualized physical therapy and stretching
Physical therapy is a planned exercise program guided by a trained therapist. The main purpose is to keep muscles as strong, flexible, and coordinated as possible. In CMT with MPZ mutation, the therapist uses gentle strengthening exercises for the lower legs and feet, balance training, and stretching of tight calf and hamstring muscles. This helps reduce contractures, prevents joints from becoming stiff, and lowers the risk of falls. The mechanism is simple: regular activity keeps nerve-dependent muscles active, supports joint alignment, and helps the brain adapt to slower nerve signals by improving balance strategies.

2. Ankle–foot orthoses (AFOs) and supportive braces
AFOs are light plastic or carbon fibre braces worn around the ankle and foot. Their purpose is to correct foot drop, improve walking, and reduce tripping. In CMT, the muscles that lift the foot become weak, so the toes drag during walking. AFOs hold the ankle in a neutral position and support the foot when swinging forward, acting like an external muscle. The mechanism is mechanical support: the brace stabilizes weak joints, absorbs some of the load, and improves alignment, which reduces energy use and improves safety and confidence while walking.Physiopedia+1

3. Custom footwear and insoles
People with CMT and MPZ mutations often develop high arches, hammertoes, or flat, unstable feet. Custom shoes and molded insoles are made to match the shape of the foot. The purpose is to distribute pressure evenly, reduce pain, and improve stability. The mechanism is simple physics: a wider base, good arch support, and cushioning decrease stress on small joints and nerves, which can lower calluses, ulcers, and joint deformity progression. Proper shoes also work together with braces to keep the ankle and foot aligned and reduce the risk of falls and ankle sprains.

4. Occupational therapy and hand function training
Occupational therapy focuses on daily activities such as buttoning clothes, writing, cooking, and using a computer. In CMT, hand muscles may weaken and sensation may decrease. The purpose is to maintain independence and safety at home, school, or work. The therapist teaches fine-motor exercises, energy-saving strategies, and suggests adaptive tools like special pens, easy-grip handles, and Velcro fasteners. The mechanism is task-specific training: repeating meaningful tasks helps the brain and remaining muscles work more efficiently, compensating for slow nerve signals and weak small muscles in the hands.

5. Balance and falls-prevention training
Because CMT causes weakness and sensory loss in the feet, people often feel unsteady and fall. Balance training programs use exercises such as standing with feet close together, single-leg stands, stepping over obstacles, and walking on different surfaces under supervision. The purpose is to retrain the brain and muscles to use vision, inner ear, and remaining sensation to keep balance. The mechanism is neuroplasticity: the nervous system can learn new strategies and strengthen reflexes, which reduces falls, improves confidence, and may slow loss of mobility.

6. Gait training and walking aids
Gait training means practicing better walking patterns with a therapist. In CMT, people may develop a “steppage gait” with high lifting of the knee to clear the foot. The therapist teaches how to use braces, choose proper step length, and coordinate arms and legs. If needed, canes or trekking poles are introduced. The purpose is efficient, safe walking with less fatigue. The mechanism is biomechanical: changing step pattern and providing extra support reduces stress on weak muscles, lowers joint overload, and makes movement more energy-efficient.

7. Hydrotherapy and aquatic exercise
Hydrotherapy uses warm water pools for exercise. The purpose is to allow people with weak muscles and poor balance to move more freely and safely. In water, buoyancy supports body weight so joints and muscles carry less load, while water resistance provides gentle strengthening and cardiovascular training. The mechanism is reduced gravity and even pressure: this combination makes it easier to practice walking, kicking, and stretching with less pain and lower risk of falling, which is especially helpful for CMT patients with significant foot deformity or fatigue.

8. Pain psychology, cognitive-behavioural therapy, and coping skills
Chronic neuropathic pain and disability can cause anxiety, low mood, and poor sleep. Pain psychology and cognitive-behavioural therapy (CBT) help people understand the pain, change negative thoughts, and use relaxation or pacing techniques. The purpose is to reduce the emotional burden of pain and improve function even when some pain remains. The mechanism is brain-based: thoughts and emotions strongly influence how the brain processes pain signals. By changing attention, expectations, and stress responses, CBT can reduce perceived pain intensity and improve quality of life in CMT.Charcot-Marie-Tooth Association+1

9. Lifestyle exercise and activity planning
Regular low-impact exercise such as walking on flat ground, cycling, or swimming is important. The purpose is to maintain overall health, manage weight, and keep muscles and heart strong without over-tiring weak nerves. The mechanism is conditioning: gentle repeated movement improves blood flow to nerves and muscles, supports bone health, and reduces fatigue. Activity should be balanced with rest so muscles are challenged but not overworked, because over-exertion can worsen weakness in inherited neuropathies.

10. Foot care and skin protection
Loss of feeling in the feet means small injuries may go unnoticed and can become ulcers or infections. Good foot care includes daily inspection of the skin, careful nail trimming, avoiding walking barefoot, and wearing well-fitting socks and shoes. The purpose is to prevent wounds, infections, and, in severe cases, bone or joint damage. The mechanism is basic prevention: early detection and avoidance of mechanical pressure or friction give the skin time to heal and protect the already vulnerable nerves and soft tissues.

11. Vocational counselling and workplace adaptations
CMT can make some jobs hard, especially those needing heavy physical work or fine hand skills. Vocational counselling helps match a person’s abilities with appropriate work and suggests modifications like ergonomic chairs, footrests, voice-to-text software, and flexible schedules. The purpose is to keep people employed and independent for as long as possible. The mechanism is social and environmental support: changing the job environment instead of the person reduces strain on weak muscles and lessens fatigue.

12. Genetic counselling for family planning
Because MPZ-related CMT is usually autosomal dominant, there is a 50% chance of passing the mutation to each child. Genetic counselling explains inheritance, offers genetic testing to adults at risk, and discusses options such as pre-implantation genetic testing. The purpose is to support informed decisions and reduce anxiety. The mechanism is knowledge: understanding the gene and risks helps families plan pregnancies and manage psychological stress.Genetic Rare Diseases Center+2Clinical Actionability+2

(To stay within your word limit, I focused on 12 of the most important non-pharmacological therapies in depth rather than a very long list of 20 almost-repeated items.)

---

Drug treatments to manage symptoms

Important: There is currently no FDA- or EMA-approved drug that cures Charcot-Marie-Tooth disease or directly fixes MPZ mutations. Drug treatment is aimed at controlling neuropathic pain, muscle cramps, sleep problems, and mood problems. Most evidence comes from neuropathic pain in other conditions (such as diabetic neuropathy or postherpetic neuralgia), and these medicines are used off-label in CMT under specialist advice.Medscape Emphasis+4NCBI+4PMC+4

Safety note: The information below is educational. Exact dosing and timing must be decided by a doctor, especially for children and teenagers.

1. Gabapentin (Neurontin, Gralise, Horizant)
Gabapentin is an antiepileptic drug widely used for neuropathic pain. It is FDA-approved for postherpetic neuralgia, with typical adult total daily doses between about 900–3600 mg divided into several doses, according to the label.FDA Access Data+3FDA Access Data+3FDA Access Data+3 In CMT, gabapentin is used off-label to reduce burning, shooting, or electric-shock pain from damaged nerves. Its purpose is to calm misfiring sensory nerves and improve sleep. Mechanistically, gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the nervous system, reducing the release of excitatory neurotransmitters. Common side effects include dizziness, sleepiness, and swelling of legs.

2. Pregabalin (Lyrica, Lyrica CR)
Pregabalin is related to gabapentin and is FDA-approved for several neuropathic pain conditions and fibromyalgia, with adult doses commonly 150–600 mg per day in divided doses, guided by kidney function and response.FDA Access Data+3FDA Access Data+3FDA Access Data+3 In CMT, it is again used off-label to manage severe nerve pain, tingling, and sleep disruption. The purpose is to lower pain intensity and improve quality of life. The mechanism is similar to gabapentin: it modulates calcium channels and decreases excitatory neurotransmitter release. Side effects include dizziness, drowsiness, weight gain, and peripheral edema.

3. Duloxetine (Cymbalta)
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that is FDA-approved for diabetic peripheral neuropathic pain and fibromyalgia. It is often prescribed around 30–60 mg once daily, with adjustments based on response and tolerability.FDA Access Data+2Springer Link+2 In MPZ-related CMT, duloxetine may be chosen when there is both nerve pain and low mood or anxiety. Its purpose is dual: improve pain and support emotional well-being. Mechanistically, it increases serotonin and norepinephrine in pain-modulating pathways of the brain and spinal cord, which can dampen pain signals. Common side effects include nausea, dry mouth, sweating, and sometimes raised blood pressure.

4. Amitriptyline (low-dose tricyclic antidepressant)
Amitriptyline is a tricyclic antidepressant often used at low doses at night (for example 10–50 mg in adults) for neuropathic pain and insomnia, based on guideline recommendations for neuropathic pain.Springer Link+2Charcot-Marie-Tooth Association+2 In CMT, its purpose is to reduce pain, improve sleep, and sometimes treat depression. It works by blocking reuptake of serotonin and norepinephrine and blocking sodium channels, which lowers pain transmission. Side effects include dry mouth, constipation, weight gain, and drowsiness. It must be used carefully in people with heart disease or risk of overdose.

5. Nortriptyline (tricyclic antidepressant)
Nortriptyline is similar to amitriptyline but often somewhat better tolerated in older adults. It is used off-label for neuropathic pain and may be started at a low dose at night and slowly increased. The purpose is again to cut pain intensity and improve sleep. Mechanistically, it blocks reuptake of norepinephrine and serotonin and modulates sodium channels in pain pathways. Clinical trials in neuropathic pain show that tricyclics provide meaningful pain relief for many patients, although side effects such as dry mouth, constipation, and dizziness are common.ResearchGate+1

6. Carbamazepine and oxcarbazepine
Carbamazepine and oxcarbazepine are antiepileptic drugs that can help stabbing, shooting neuropathic pain. They are also used for trigeminal neuralgia. In CMT, they may be used when pain has a severe, shock-like pattern. Their purpose is to stabilize overly active sensory nerves. The mechanism is blockade of voltage-gated sodium channels, which reduces repetitive firing in damaged nerves. Doses are titrated slowly to avoid side effects such as dizziness, low sodium levels, and rarely serious skin reactions.Medscape Emphasis+1

7. Topical lidocaine 5% patch or gel
Lidocaine patches or gels are applied on painful skin areas, usually for up to 12 hours a day in adults. They are FDA-approved for postherpetic neuralgia and used off-label for focal neuropathic pain. The purpose in CMT is to numb very painful spots, for example on the feet, without systemic side effects. The mechanism is local sodium channel blockade in cutaneous nerves, which reduces signal transmission. Because it acts only where applied, common side effects are limited to skin irritation or redness.

8. Topical capsaicin (low-dose cream or high-dose patch)
Capsaicin cream or a high-dose patch (8%) is used in neuropathic pain guidelines as a second-line option.Springer Link+1 The purpose is to reduce superficial burning pain. Capsaicin activates and then desensitizes TRPV1 receptors on pain fibres, leading to temporary depletion of substance P and other pain transmitters. At first, burning may become stronger, but over days or weeks the treated area becomes less sensitive. Side effects include local burning and redness, so treatment must be done under guidance, especially with strong patches.

9. Baclofen and tizanidine (muscle relaxants)
Some people with CMT develop painful muscle cramps and spasticity-like tightness. Baclofen and tizanidine are muscle relaxants sometimes used to ease these symptoms. The purpose is to reduce muscle over-activity, lessen cramps, and make movement and sleep easier. Baclofen acts mainly as a GABA-B receptor agonist, lowering excitability of motor neurons in the spinal cord. Tizanidine acts as an α2-adrenergic agonist. Both can cause drowsiness, dizziness, and low blood pressure, so doses must be titrated slowly and never stopped suddenly.

10. Tramadol and other analgesics (used cautiously)
For severe pain not controlled by first-line neuropathic medicines, doctors may occasionally use tramadol or other analgesics. Tramadol is a weak opioid and SNRI-like drug that can reduce acute flares of pain but has risks of dependence, nausea, dizziness, and seizures, so it is not a first choice and must be used carefully. Simple analgesics like paracetamol and NSAIDs (ibuprofen, naproxen) may help mild musculoskeletal pain from joint stress, but they are usually less effective for neuropathic pain. The mechanism is modulation of opioid receptors and inhibition of pain-related transmitters.

(Again, I focused on 10 core drug options in depth to stay within your word limit, all of which are supported by neuropathic pain evidence and/or FDA labels, but are used off-label in CMT.)FDA Access Data+5Charcot-Marie-Tooth Association+5Springer Link+5

---

Dietary molecular supplements and nutrition support

Evidence for supplements in MPZ-related CMT is limited, and no supplement cures the disease. Some are studied in other neuropathies and may support nerve health. Always discuss with a doctor.

1. Omega-3 fatty acids (fish oil)
Omega-3 fatty acids (EPA and DHA) from fish oil help reduce inflammation and support cell membrane health. The purpose is general cardiovascular and nerve support. Mechanistically, omega-3s are incorporated into nerve cell membranes and may improve fluidity and anti-inflammatory signalling. Typical supplemental doses for adults are often in the range of 500–1000 mg EPA+DHA per day, but the exact dose should be individualised. Side effects can include fishy aftertaste and mild stomach upset, and high doses may increase bleeding risk when combined with blood thinners.

2. B-complex vitamins (especially B1, B6, B12, but avoiding excess B6)
B-vitamins are important for nerve energy metabolism and myelin maintenance. The purpose is to correct any deficiency that could worsen neuropathy. Vitamin B12 and B1 deficiency can clearly damage nerves. Mechanistically, these vitamins act as co-factors in energy production and myelin synthesis. Supplement doses vary, but they are generally modest daily doses unless a deficiency is diagnosed. Very high doses of vitamin B6 can actually cause neuropathy, so balanced B-complex under medical advice is important.

3. Vitamin D
Vitamin D supports bone health and may have neuro-immune roles. In people with limited mobility from CMT, vitamin D deficiency is common due to less outdoor activity. The purpose is to maintain strong bones and possibly support neuromuscular function. Mechanistically, vitamin D acts through nuclear receptors to regulate calcium metabolism and muscle function. Dosing depends on blood levels; common maintenance doses are a few hundred to a couple of thousand IU per day in adults, as advised by a doctor. Excessive doses can cause high calcium and kidney problems.

4. Alpha-lipoic acid (ALA)
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. It helps neutralize free radicals and may support blood flow to nerves. The purpose in CMT would be to provide general antioxidant support, although direct evidence is limited. Mechanistically, ALA participates in mitochondrial energy reactions and regenerates other antioxidants like vitamins C and E. Oral doses in studies of diabetic neuropathy often range around 600 mg/day, but this should only be used under medical guidance because it can affect blood sugar and interact with other medicines.

5. Acetyl-L-carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria and has been studied in peripheral neuropathy. The purpose is to support nerve energy metabolism and possibly reduce pain. Mechanistically, it may promote nerve regeneration and mitochondrial function. Doses in research were often 1–3 g/day in adults, divided into several doses, but its role in CMT is still experimental. Side effects can include stomach upset and a “fishy” body odour in some people.

6. Coenzyme Q10 (CoQ10)
CoQ10 is a component of the mitochondrial respiratory chain and an antioxidant. The purpose is to support energy production in muscles and nerves. Mechanistically, CoQ10 helps electron transport and reduces oxidative stress in mitochondria. Supplemental doses for general health often range from 50–200 mg/day in adults, though exact dosing should be personalized. It can cause mild digestive upset and may interact with blood-thinning drugs.

7. Magnesium
Magnesium is involved in nerve signalling and muscle relaxation. In CMT, low magnesium may worsen cramps and twitching. The purpose of supplementation is to correct deficiency and ease muscle discomfort. Mechanistically, magnesium blocks NMDA receptors and stabilizes cell membranes, reducing excitability of nerves and muscles. Typical oral doses are around 200–400 mg elemental magnesium per day in adults, depending on diet and kidney function. Too much can cause diarrhoea and, in severe kidney disease, high blood magnesium.

8. Antioxidant vitamins C and E
Vitamins C and E help neutralise oxidative stress, which may contribute to nerve damage in many conditions. The purpose in CMT is supportive: to help protect cell membranes and proteins from free radical damage. Mechanistically, vitamin E protects lipid membranes, and vitamin C regenerates oxidised vitamin E. Both are usually obtained from a balanced diet rich in fruits and nuts, with supplements used only if intake is low. Very high doses may cause side effects like stomach upset or, rarely, bleeding problems (with high vitamin E).

9. Curcumin (from turmeric)
Curcumin is a plant compound with anti-inflammatory and antioxidant properties. Some animal studies suggest benefit for nerve inflammation, but human data in CMT are lacking. The purpose is experimental support for inflammation control. Mechanistically, curcumin modulates NF-κB and other inflammatory pathways. Supplements often use doses of a few hundred milligrams per day with added piperine to improve absorption. Side effects can include stomach upset and interactions with blood thinners.

10. Resveratrol and polyphenol-rich foods
Resveratrol from grapes and berries is another antioxidant studied for neuroprotective effects in cells and animals. The purpose is general support of nerve health and vascular function. Mechanistically, resveratrol activates sirtuin pathways and may improve mitochondrial function. Instead of high-dose supplements, many doctors prefer a diet rich in colourful fruits, vegetables, and whole grains to provide a wide range of polyphenols. Excess supplemental resveratrol can cause digestive issues and may interact with medicines.

---

Experimental immunity-booster, regenerative and stem-cell-related approaches

Right now, there are no approved stem cell or gene therapies for MPZ-related CMT, but research is ongoing.MDPI+2Taylor & Francis Online+2 Any such treatment should only be used in strictly controlled clinical trials.

1. Gene therapy to correct or silence MPZ mutations
Research groups are exploring ways to silence harmful MPZ alleles or replace them with healthy copies using viral vectors or gene-editing tools. The purpose is to correct the underlying cause rather than just treating symptoms. Mechanistically, techniques like AAV-mediated delivery or CRISPR-based editing aim to restore proper myelin protein zero function in Schwann cells. Dosing, timing, and safety are still being studied in pre-clinical and very early clinical work, so this is not yet available as routine care.

2. Small-molecule “proteostasis” modulators
Some MPZ mutations cause misfolded protein that stresses Schwann cells. Researchers are testing small molecules that improve protein folding, enhance the unfolded protein response, or promote degradation of misfolded MPZ. The purpose is to protect Schwann cells from chronic stress and death. Mechanistically, these drugs act on chaperone systems or quality-control pathways in the endoplasmic reticulum. Studies are mostly in cells and animal models, so dosing and safety are not defined for patients yet.

3. Neurotrophic factors (nerve growth–supporting molecules)
Neurotrophins such as nerve growth factor or neurotrophin-3 have been studied experimentally to support nerve survival and myelination. The purpose is to boost natural regeneration pathways, helping damaged nerves survive and function better. Mechanistically, these proteins bind to receptors on neurons and Schwann cells to activate growth and survival signalling. Earlier trials faced challenges with side effects and delivery to nerves, so newer approaches focus on targeted delivery systems.

4. Mesenchymal stem cell therapies
Mesenchymal stem cells (MSCs) from bone marrow or fat are being studied in many neurological diseases. The idea is that they may release growth factors and anti-inflammatory molecules that help nerves indirectly. The purpose is not to replace nerves directly but to create a better environment for repair. Mechanistically, MSCs secrete cytokines and exosomes that can modulate immune responses and support Schwann cells. These therapies are experimental and should only be received inside regulated clinical trials.

5. Immune-modulating biologics (in selected rare cases)
For some rare MPZ-related neuropathies with overlapping immune features, doctors may try immune-modulating drugs such as intravenous immunoglobulin (IVIG) or steroids, but this is not standard for typical CMT1B. The purpose in these unusual cases is to reduce immune-mediated damage on top of genetic vulnerability. Mechanistically, IVIG and other biologics change antibody and cytokine profiles. Because of significant risks, they are reserved for very specific situations under specialist supervision.

6. Combination approaches (rehabilitation plus future disease-modifying agents)
Research papers suggest that when effective disease-modifying therapies become available in the future, they will still need to be combined with physical therapy, orthotics, and surgery.MDPI+2Taylor & Francis Online+2 The purpose of this combined approach is to treat both the root cause and the established deformities. The mechanism is simple: while drugs or gene therapy may protect nerves, they cannot undo fixed bone or joint changes, so long-term care will always include rehabilitation and orthopaedic support.

---

Surgical treatments

Surgery does not cure CMT but can correct deformities that cause pain and disability.Physiopedia+2Muscular Dystrophy Association+2

1. Tendon transfer surgery
In CMT, some muscles become weak while others stay stronger. Tendon transfer surgery moves a functioning tendon to take over the job of a weak one, often around the ankle and foot. The purpose is to improve foot position and walking, reduce foot drop, and balance muscle forces. During the procedure, the surgeon detaches a tendon from its original insertion and attaches it to a new bone or tendon. Over time, rehabilitation teaches the “old” muscle to perform the new movement.

2. Osteotomy (bone-cutting to correct foot shape)
High arches or other severe deformities can make shoes painful and walking unstable. In an osteotomy, the surgeon cuts and repositions bones in the foot to create a flatter, more balanced shape. The purpose is to improve weight distribution and reduce pressure points. Plates, screws, or pins hold the bones in their new alignment while they heal. This mechanical correction can greatly improve comfort and stability.

3. Joint fusion (arthrodesis)
In very unstable or arthritic joints, especially in the hindfoot, joints may be fused so they no longer move. The purpose is to provide a stable, pain-free base for standing and walking. In arthrodesis, damaged joint surfaces are removed and the bones are held together with screws until they grow into one solid bone. This reduces pain from abnormal motion but sacrifices flexibility.

4. Soft-tissue release for tight tendons
Tight heel cords (Achilles tendons) and plantar fascia can pull the foot into an abnormal position. Soft-tissue release surgery lengthens or releases these structures. The purpose is to allow the foot to rest in a more neutral position and to make bracing easier. The surgeon carefully cuts or lengthens the tendon or fascia, then the limb is placed in a cast or boot while it heals in the corrected position.

5. Correction of hand deformities
In some people, CMT and MPZ mutations cause clawing of the fingers and thumb weakness. Hand surgery can include tendon transfers, joint releases, or fusions to improve grip and pinch. The purpose is to make daily tasks such as holding utensils or typing easier. As in the foot, the mechanism is mechanical correction of muscle imbalance and joint malalignment, followed by therapy to retrain movement.

---

Prevention and lifestyle protection strategies

You cannot prevent being born with an MPZ mutation, but you can reduce complications.

1. Avoid nerve-toxic medicines (for example, the chemotherapy drug vincristine is known to worsen hereditary neuropathies; always tell doctors you have CMT).NCBI+1

2. Keep a healthy body weight to reduce stress on weak feet and joints and make walking easier.

3. Do regular, gentle exercise like swimming or cycling to maintain strength and endurance without overworking muscles.

4. Use braces and supports early when recommended, instead of waiting until falls become frequent.

5. Protect your feet with good shoes, daily inspection, and prompt care of blisters or cuts.

6. Stop smoking, because smoking reduces blood flow to nerves and can worsen neuropathy.

7. Limit alcohol, as heavy drinking can damage nerves.

8. Keep chronic conditions such as diabetes or thyroid disease under good control, because they can add extra nerve damage.

9. Get vaccinations to reduce severe infections that might keep you bedridden and weaken muscles further.

10. Attend regular follow-up visits with your neuromuscular team to monitor progression and adjust braces, therapies, or medications.

---

When to see doctors

You should see a doctor, ideally a neurologist with experience in neuromuscular diseases, if you or your child notice:

• New or slowly worsening weakness in the feet, hands, or legs

• Frequent tripping, ankle sprains, or new foot deformities

• Loss of feeling, burning, or electric-shock pain in feet or hands

• Problems with balance, especially in the dark or on uneven ground

• Difficulty with fine hand tasks such as buttoning or writing

• Rapid changes in walking or hand function, which may suggest a new problem on top of CMT

• Severe or new pain that does not improve with simple measures

• Any side effects from medicines such as strong dizziness, swelling, mood changes, or allergic reactions

Emergency care is needed if there is sudden severe weakness, loss of bladder or bowel control, or breathing problems, because these are not typical of slow, inherited CMT and may mean an additional urgent disease.

---

What to eat and what to avoid

1. Eat a balanced diet rich in vegetables, fruits, whole grains, lean protein, and healthy fats to support general nerve and muscle health.

2. Include foods with omega-3s, such as fatty fish (salmon, sardines) or flaxseed, for anti-inflammatory support.

3. Ensure enough protein (beans, eggs, fish, poultry) to maintain muscle mass, especially if mobility is limited.

4. Choose foods rich in B-vitamins, like whole grains, leafy greens, and lean meats, to support nerve function.

5. Maintain adequate vitamin D and calcium, through dairy or fortified foods and sensible sun exposure, to keep bones strong.

6. Limit sugary drinks and refined sweets, which can promote weight gain and, in the long term, diabetes that harms nerves.

7. Avoid heavy alcohol use, which is toxic to nerves and can worsen neuropathy.

8. Limit highly processed and very salty foods, which can contribute to weight gain, blood pressure problems, and swelling.

9. Stay well hydrated, because dehydration can worsen fatigue and cramps.

10. Avoid extreme fad diets, especially very low-calorie or unbalanced diets, because they may cause nutrient deficiencies that further harm nerves.

---

Frequently asked questions (FAQs)

1. Can Charcot-Marie-Tooth disease caused by MPZ mutation be cured?
At present, there is no cure and no drug that stops or reverses MPZ-related CMT.Taylor & Francis Online+3NCBI+3PMC+3 Treatment focuses on physical therapy, orthotics, surgery, pain control, and lifestyle measures. Research into gene therapy and other disease-modifying treatments is active, but these options are still experimental.

2. Is MPZ-related CMT always severe?
No. Some MPZ mutations cause early and severe neuropathy, while others cause milder symptoms starting in adulthood. Even within the same family, severity can vary.NCBI+3Genetic Rare Diseases Center+3Orpha.net+3

3. Will I end up in a wheelchair?
Many people with CMT never need a wheelchair and stay mobile with braces and therapy. Others may need a wheelchair for long distances or later in life. Early rehabilitation, good foot care, and appropriate surgery when needed can help maintain walking ability longer.

4. Is pain common in MPZ-related CMT?
Pain is not universal in all CMT types but appears to be more common in some MPZ mutations.MDPI+1 Neuropathic pain can usually be improved with medicines like gabapentin, pregabalin, duloxetine, or tricyclics, plus non-drug strategies such as CBT and physical therapy.

5. Is exercise safe if I have CMT?
Yes, gentle, low-impact exercise is usually safe and recommended. Intense, high-impact exercise or heavy weight-lifting that causes repeated muscle injury should be avoided. A physiotherapist can design a safe program for your specific level of weakness and balance.

6. Can diet alone treat CMT?
Diet cannot fix the MPZ mutation, but healthy eating helps weight control, bone strength, and general health, which all support mobility and quality of life. Supplements may correct deficiencies but do not replace medical care or physical therapy.

7. Should my family members get genetic testing?
Genetic counselling is very important. Adult relatives may choose genetic testing to clarify their risk and for family planning. In many guidelines, predictive genetic testing in children without symptoms is approached carefully and often delayed until they can decide for themselves.Clinical Actionability+1

8. Can pregnancy make CMT worse?
Some women notice temporary worsening of symptoms during pregnancy due to weight gain and fluid shifts, while others do not. Careful planning with obstetric and neurology teams helps manage falls risk, pain, and delivery planning. CMT itself does not usually prevent pregnancy.

9. Are there medicines I must avoid?
Certain drugs, especially the chemotherapy agent vincristine and some other neurotoxic drugs, can markedly worsen hereditary neuropathies, including CMT.NCBI+1 Always tell any doctor or dentist that you have CMT before starting new medicines.

10. How often should I see my neurologist or specialist?
Most people with stable CMT are reviewed every 6–12 months. If you notice rapid changes, new pain, or frequent falls, you should see your team sooner. Children may need more frequent visits while they grow and their braces and shoes need updating.

11. What is the difference between CMT1B and other CMT types?
CMT1B is specifically caused by MPZ gene mutations and usually involves demyelinating neuropathy. Other types, such as CMT1A (PMP22 duplication) or CMT2 (axonal forms), involve different genes and mechanisms. Clinical features overlap, but genetic testing is needed to know the exact type.Wikipedia+3Genetic Rare Diseases Center+3CMT Research Foundation+3

12. Will surgery stop my disease from progressing?
No. Surgery can correct fixed deformities and reduce pain, but it does not slow the underlying nerve disease. After surgery, ongoing therapy and bracing are still needed, and nerve damage may continue over time.

13. Can children with MPZ-related CMT play sports?
Many children can join non-contact, low-impact sports such as swimming, cycling, or adapted games. Sports that involve heavy jumping, sudden changes in direction, or a high risk of ankle injuries may need to be modified or avoided. A paediatric neurologist and physiotherapist can give individual advice.

14. Are there support groups for people with CMT?
Yes. National and international CMT organisations and patient foundations provide information, support groups, and updates on research and clinical trials. They can help with coping, advocacy, and connecting families with similar experiences.Charcot-Marie-Tooth Association+2Muscular Dystrophy Association+2

15. What is the outlook (prognosis) for MPZ-related CMT?
Most people with MPZ-related CMT have slowly progressive symptoms over many years and can maintain independence with proper support. Life expectancy is usually near normal. The outlook depends on the specific mutation, severity of weakness and deformity, and access to rehabilitation, surgery, and pain management.NCBI+2Genetic Rare Diseases Center+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 23, 2025.